PHARMACOGENOMICS JOURNAL

The Pharmacogenomics Journal (ISSN 1470-269X) is a peer-reviewed scientific journal published monthly by Springer Nature, with its primary publishing location in the United Kingdom. The journal is indexed in SCI (Science Citation Index) and has a current impact factor that varies annually, typically reflecting its moderate influence in the field. It is not fully open access (OA), though some articles may be available under hybrid OA options. In the Chinese Academy of Sciences (CAS) journal ranking system, it is categorized within the relevant pharmacology or genetics divisions, often in Q2 or Q3 depending on the year. The journal focuses on pharmacogenomics and personalized medicine, publishing research on genetic variations affecting drug response, biomarker discovery, and clinical applications of genomic data. Its发文特点 include original research articles, reviews, and translational studies bridging genomics and therapeutics. While the journal maintains a reputable standing due to its association with Springer Nature and its specialized niche, potential risks include variability in impact factor and competition from broader-scope journals. Overall, it serves as a dedicated platform for researchers in pharmacogenomics but may face challenges in visibility compared to higher-impact multidisciplinary journals.